The efficient export of a subset ofEscherichia coli envelope proteins is dependent upon the product of the secB gene. Previous studies indicated that SecB promotes the export of the periplasmic maltose-binding protein (MBP) by preventing premature folding of the precursor MBP in the cytoplasm into an export-incompetent form. In this study, SecB has been purified to homogeneity and shown to be a soluble, cytoplasmic, multimeric protein composed of identical 17-kDa subunits. SecB was required for efficient in vitro translocation of MBP into inverted membrane vesicles. The addition of purified SecB to an in vitro system prepared from SecB-cells significantly enhanced MBP translocation. The purified protein also quantitatively retarded folding of precursor MBP into a stable, protease-resistant conformation in the absence of membranes. Finally, the inclusion of excess purified SecB in a SecB+ in vitro system significantly prolonged the time in which precursor MBP remained competent for posttranslational import into membrane vesicles.
A number of components of the protein export machinery of Escherichia coli have been identified by genetic approaches [reviewed by Oliver (1) ] and by biochemical approaches using in vitro protein translocating systems (2) (3) (4) . The export of a subset of envelope proteins, including the periplasmic maltose-binding protein (MBP), is adversely affected by mutations in secB, a nonessential gene that maps near min 81 on the E. coli chromosome (5, 6) . We have presented (7) evidence that the SecB protein functions as an antifolding factor that specifically interacts with the mature region of the precursor MBP (pre-MBP) to prevent its premature folding in the cytoplasm into a translocation-incompetent form. Kumamoto and Gannon (8) reached a similar conclusion by using a different experimental approach. Thus a specific biochemical function was assigned to the product of an E. coli sec gene, which complemented earlier work by Randall and Hardy (9) correlating the folding of pre-MBP into its stable tertiary structure in the cytoplasm with the loss ofexport competence. The essential role of protein conformation during membrane translocation has been recognized in eukaryotic cells as well (10) . For example, unfolding factors that facilitate translocation of proteins into the endoplasmic reticulum and mitochondria have been described (11, 12) .
An understanding ofprotein export in E. coli will be greatly aided by the purification and characterization of the individual components that mediate this process and eventual reconstitution of a complete protein translocating system in vitro. This study was undertaken to demonstrate the SecB dependence of MBP translocation in vitro and to purify biologically active SecB capable of interacting with newly synthesized pre-MBP to retard its folding and promote its import into membrane vesicles.
MATERIALS AND METHODS
In Vitro MBP Synthesis and Translocation. MBP was synthesized in vitro by using a coupled E. coli transcriptiontranslation system, in the presence or absence of membrane vesicles, and plasmid templates in which the wild-type malE or malEAJ16 alleles were under transcriptional control of the lacUV5 promoter-operator, as described (7, 13) . Cells of strain MC4100 (14) and CK1953 [MC4100 secB::TnS (6)] used for the preparation of reaction components (S-30, S-100, membrane-free ribosomes, and inside-out cytoplasmic membrane vesicles) were grown at 30'C to an OD600 of 1.0 in TB medium (pH 7.8) containing 0.2% glucose. To assess translocation, half of each sample was treated with proteinase K (55 Ag/ml). All of the samples were solubilized by boiling in 1% NaDodSO4, and then the MBP species were immunoprecipitated and analyzed by NaDodSO4/PAGE in 10% polyacrylamide gels and autoradiography (15) . The amount of radioactivity present as pre-MBP and mature MBP was quantitated as described (7 (19) and plasmid pJW25 were grown at 30'C to an OD6w of 1.5 in LB medium (pH 7.8) and then induced with 1 mM isopropyl thiogalactoside for 2 hr. The cell pellet (4.4 g) was washed once, and then suspended in 20 ml of lysis buffer [20 mM Tris'HCI (pH 7.4) containing 2 mM EDTA, 0.1 mM phenylmethylsulfonyl fluoride, and lysozyme at 100 ,ug/ml]. The cells were incubated at 00C for 10 min, then MgSO4 (5 mM) and DNase I (10 ttg/ml) were added, and, after 10 min of further incubation, the mixture was centrifuged at 30,000 x g for 15 min. The pellet was resuspended in lysis buffer and the process was repeated. The supernatant fluids were combined, dialyzed overnight against 20 tTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. methylsulfonyl fluoride, and centrifuged at 30,000 x g for 20 min. The soluble extract was applied to a 1.5 x 10 cm column of Q-Sepharose (Pharmacia), equilibrated with the same buffer, washed with 30 ml of buffer, and the proteins were eluted with a NaCl gradient of 0-500 mM (total volume, 300 ml). Fractions were assayed by NaDodSO4/PAGE; the SecB-containing fractions (eluted at 0.3 M NaCl) were pooled, precipitated with 80% (wt/vol) ammonium sulfate, and dialyzed overnight against 50 mM potassium phosphate (pH 7.4) containing 150 mM NaCl and 0.1 mM phenylmethylsulfonyl fluoride. The dialyzed extract was concentrated to 2 ml with Centricon concentrators (Amicon; molecular weight cut-off, 10 ,000) and chromatographed on a 1.5 x 100 cm S-200 HR (Pharmacia) gel filtration column. The peak tubes of SecB-containing fractions were pooled, concentrated with the Centricon concentrators, and rechromatographed on the same S-200 HR column.
Protein concentration was determined by the method of Lowry et al. (20) with bovine serum albumin as a standard. Quantitation of purity was determined by use of a LKB laser scanner after staining and destaining NaDodSO4/PAGE gels. Isoelectric focusing was performed as described (21) utilizing Pharmalyte pH 2.5-5.0 ampholytes (Pharmacia).
In Vivo Radiolabeling ofCellular Proteins. Cells were grown in glycerol minimal medium to midlogarithmic phase and radiolabeled with [35S]methionine for 10 min, as described by Rasmussen et al. (13) . Incorporation of label was terminated by precipitation with trichloroacetic acid. SecB was immunoprecipitated from detergent-solubilized cell extracts and analyzed by NaDodSO4/PAGE and autoradiography. AntiSecB rabbit IgG was affinity-purified using SecB coupled to Sepharose CL-4B beads (Pharmacia), after DEAE-cellulose column chromatography.
In Vitro Assay ofMBP Folding. MBP was synthesized in the absence of membranes, and at each time point an aliquot was removed and quickly diluted into ice-cold 40 mM triethanolamine acetate (pH 7.8) containing 0.5% methionine. Half of each sample was immediately treated with proteinase K (55 ,ug/ml), and the MBP species were immunoprecipitated and analyzed by NaDodSO4/PAGE as described above. The percent of precursor that was sensitive to proteolysis was calculated as described by Randall and Hardy (9 by using an S-30 fraction, an S-100 fraction plus added wild-type ribosomes, or an S-100 fraction plus added ribosomes and vesicles (MB). Fractions were prepared from wild-type SecB1 cells (strain MC4100; designated B+) and SecB-cells [strain CK1953
(secB::TnS); designated B-]. After the reaction mixtures were incubated for 15 min, half of each sample was treated with proteinase K. Subsequently, MBPA116 was immunoprecipitated and analyzed by NaDodSO4/PAGE and autoradiography. The lanes containing the protease-treated samples were exposed to film twice as long as untreated samples. The positions of precursor (p) and mature (m) MBPA116 are indicated by arrows. The percentage oftotal MBPA116 synthesized that was protected from protease digestion (% prot) (i.e., translocated into vesicles) was calculated after measuring the amount of radioactivity present as pre-MBP and mature MBP before (-K) and after (+K) proteinase K treatment. Note that a small amount of MBPA116 was matured and protease-resistant when the SecB+ S-100 was employed without added vesicles, indicating that not all the membranes were removed when this fraction was prepared.
activity when added to a SecB+ S-100 fraction, yet little translocation occurred when the SecB-membrane vesicles were added to a SecB-S-100 fraction (18% versus 71% translocated when SecB + S-100 and membranes were employed). The combination of wild-type membrane vesicles and the SecB-S-100 fraction also resulted in an intermediate level of MBPA116 translocation activity equal to that of SecB-vesicles used with a SecB+ S-100 fraction ( Fig. 1 ).
From the above results, it was apparent that SecB was required for efficient in vitro translocation of MBP into membrane vesicles. Previous in vivo studies have revealed that efficient export of only a subset of E. coli envelope proteins is SecB-dependent (5) (6) (7) . Our in vitro analysis was consistent with those observations. In addition to MBP, translocation of the SecB-dependent oligopeptide-binding protein also was found to be deficient when SecB-fractions were employed, whereas in vitro translocation of the SecBindependent ribose-binding protein was unaffected by SecB availability (data not shown).
Purification of SecB. SecB was purified from cells containing the secB+ gene on the multicopy plasmid pJW25 under the transcriptional control of the T7 RNA polymerase. After a 2-hr induction of the T7 RNA polymerase by isopropyl thiogalactoside, a major protein band of =17 kDa, representing 30% of the total soluble protein, was easily recognized by NaDodSO4/PAGE. SecB was purified from the crude soluble fraction. An analysis of the purification procedure by NaDodSO4/PAGE is shown in Fig. 2 (Fig. 4) (7) (8) (9) . The folding of pre-MBP in the cytoplasm has been correlated with a loss in the ability of this protein to be translocated across the cytoplasmic membrane (9) . We have demonstrated (7) that SecB. MBPA116 was synthesized by using a SecB' S-30 fraction in the presence of various concentrations of purified SecB (10 ,ug of bovine serum albumin was used as a control in the reaction mixture without added SecB). After 15 min of incubation, half of each sample was treated with proteinase K. Subsequently, MBPA116 was immunoprecipitated and analyzed by NaDodSO4/PAGE and autoradiography. The lanes containing the protease-treated samples (+K) were exposed to film for a 5-fold longer period of time than untreated samples (-K). The percentage of total MBPA116 synthesized (% prot) that was protected from proteinase K digestion was calculated as described in Fig. 1. the rate of folding of wild-type pre-MBP synthesized in vitro in the absence of membranes was found to be accelerated when a SecB-S-100 fraction was used and was greatly retarded when the S-100 fraction was prepared from cells harboring the secB+ gene on a multicopy plasmid. The antifolding activity of purified SecB was investigated in this study. At intervals after the initiation of pre-MBP synthesis, aliquots were removed from the reaction and half of each sample was treated with proteinase K. If pre-MBP had completely folded, proteinase K digestion generated mature MBP; whereas if pre-MBP had not completely folded, a sufficient number ofresidues were accessible to the protease, and no polypeptides were recovered by immunoprecipitation.
When pre-MBP was synthesized using a SecB-S-100 fraction, with time there was a steady decline in the percent- (23) . We found the addition of SecB to have no measurable effect on the acquisition of proteinase K resistance when this protein was synthesized in vitro (data not shown). Excess SecB Prolongs pre-MBP Competence for Posttranslational Translocation. Posttranslational translocation can be studied independently from cotranslational translocation in an in vitro system by the addition of membranes to the reaction mixture only subsequent to the termination of protein synthesis. The effects of the inclusion of excess purified SecB on the capacity of pre-MBP to remain competent for posttranslational translocation during continued incubation at 37TC were investigated. Wild-type pre-MBP was synthesized in the absence of membrane vesicles using a SecB+ S-100 fraction. After 8 min, protein synthesis was terminated by the addition of ribonuclease, and then vesicles were added to individual aliquots of the reaction mixture at intervals to 30 min, and in each case incubation was continued for another 15 min. Since wild-type pre-MBP was synthesized in this experiment, translocation into vesicles was monitored by determining the amount of pre-MBP that was processed to mature MBP.
As shown in Fig. 6 , wild-type pre-MBP rapidly became incompetent for posttranslational import into vesicles. Translocation was undetectable if protein synthesis was terminated 20 min prior to the addition of vesicles. In marked contrast, when 2 ,ug of purified SecB was included in the reaction mixture, the proportion ofpre-MBP competent for posttranslational import immediately after the termination of protein synthesis was significantly increased. Furthermore, although translocation activity did diminish somewhat at later time points, the time period that pre-MBP remained translocationcompetent was markedly extended, such that import into vesicles was easily detectable when vesicles were added 30 min after protein synthesis termination. Effect of purified SecB on posttranslational MBP translocation. Wild-type pre-MBP was synthesized by using a SecB+ S-100 fraction plus added SecB+ ribosomes, and 2 ug of purified SecB (closed circles) or bovine serum albumin (open circles). After 8 min, protein synthesis was terminated and, at the time points indicated, SecB+ membrane vesicles were added to the reaction mixtures. Incubations were continued for another 15 min and then MBP was immunoprecipitated and analyzed by NaDodSO4/PAGE and autoradiography. The percentage of the total MBP synthesized that was processed to mature MBP was calculated after measuring the amount of radioactivity present as pre-MBP and mature MBP. Background values of processing in the absence of added vesicles were subtracted for each time point.
DISCUSSION
A component of the E. coli protein-export machinery has been purified and shown to be biologically active by several assays. SecB is an acidic protein with a monomer molecular mass of -17 kDa, as determined by its migration on NaDodSO4/PAGE. Analysis of the native protein by gel filtration chromatography and native gel electrophoresis indicated that SecB is probably a multimeric protein of four to six identical subunits. SecB was absent from cells harboring a secB::TnS mutation, and fractions prepared from such cells were markedly defective at sponsoring in vitro translocation of a subset of E. coli periplasmic proteins including MBP, thus mimicking the specific effects of the secB::Tn5 mutation on protein export in vivo (5) (6) (7) (8) . SecB appears to be a soluble cytoplasmic protein for the following reasons: (i) active SecB was purified from the soluble fraction of SecBoverproducing cells; (ii) a SecB+ S-100 fraction could partially complement membrane vesicles prepared from SecBcells for MBP translocation activity; and (iii) we had shown (7) that S-100 fractions prepared from SecB-, SecB+, and SecB-overproducing cells exhibited significant differences in the rate of folding of newly synthesized pre-MBP. A SecB-S-100 fraction also could be complemented by membrane vesicles prepared from wild-type cells. However, since SecB interacts with precursor proteins targeted for export, it was not unexpected that this protein was in both the soluble and crude membrane fractions. Furthermore, since SecB is clearly present in haploid secB+ cells in limiting quantities (7), the soluble and membrane fractions alone probably have insufficient SecB to bring MBP translocation activity in such a complementation assay up to the level obtained when both of these fractions are prepared from SecB+ cells.
The addition of purified SecB to a SecB-S-30 fraction significantly enhanced translocation of MBP into membrane vesicles, but a translocation efficiency comparable to that exhibited by SecB+ fractions was not attained. This may be an indication that SecB was somehow altered during the purification procedure or was purified away from some other component required for maximal translocation activity. Another possibility is that SecB-cells suffer alterations in their export machinery such that fractions prepared from these cells exhibit a MBP translocation defect that cannot be totally repaired by the addition of purified SecB. Providing additional SecB to a SecB+ S-30 fraction did not significantly improve MBP translocation efficiency. Thus, a limiting amount of available SecB probably is not responsible for the inability to import MBP into vesicles in vitro with 100% efficiency.
Consistent with our previous findings that SecB had an antifolding activity that promoted MBP export (7), we found that purified SecB added to a SecB-S-100 fraction could significantly retard the folding ofnewly synthesized pre-MBP into a protease-resistant form. By this assay, folding of pre-MBP was virtually undetectable over the time course of the experiment when 2 ,ug of SecB was added to the in vitro reaction mixture. This effect on pre-MBP folding was identical to that obtained with an S-100 fraction prepared from SecB-overproducing cells (7) . Thus, purified SecB must still retain the ability to specifically interact with pre-MBP in such a manner as to significantly affect its folding kinetics. Our earlier studies had strongly suggested that SecB binds to a specific site within the mature moiety of the pre-MBP to effect its antifolding activity, although at this point alternative explanations for this antifolding activity cannot be ruled out (7) . The correlated with the loss in its ability to be posttranslationally translocated. We subsequently showed that posttranslational MBP export was particularly defective in SecB-cells and concluded that the antifolding activity of SecB was essential for maintaining the export competence of pre-MBP in the cytoplasm (7) . In this study, we have found that the rapid loss in the ability of wild-type pre-MBP synthesized in vitro to be posttranslationally imported into vesicles could be significantly slowed by the inclusion of excess purified SecB, well above the haploid SecB level, in the reaction mixture. The interaction between SecB and wild-type pre-MBP in vivo is by necessity a transient one since translocation is normally achieved very rapidly. When translocation is prevented, pre-MBP folding in the cytoplasm eventually occurs even in the presence of SecB (7, 8) . However, it seems clear from our in vitro studies that an elevated level of SecB can markedly affect pre-MBP folding kinetics, possibly by shifting the equilibrium of the pre-MBP-SecB interaction in favor of the association. As an alternative to adding excess SecB, pre-MBP competence for posttranslational import into vesicles also could be significantly prolonged by a mutational alteration in the pre-MBP that adversely affected folding (J.B.W., unpublished data). These findings underscore the importance of an antifolding factor in promoting the posttranslational translocation of MBP.
What about cotranslational MBP export which also is defective in SecB-cells (7, 8) ? Cotranslational translocation of MBP is not initiated until after =80%o of the nascent chain has been synthesized (25) , which includes that portion of the pre-MBP having the SecB interaction site (7) . The antifolding activity of SecB might promote cotranslational pre-MBP export by preventing the nascent chain from assuming a conformation that is inhibitory to export or by keeping the nascent chain in a conformation that ensures that the signal peptide is readily accessible to the export machinery. On the other hand, it has been suggested that a possible second function of SecB is to actively facilitate the delivery of nascent pre-MBP to the export machinery in the cytoplasmic membrane, perhaps by directly interacting with a membrane receptor (7, 8) . It could be that the loss of this putative second activity is primarily responsible for the defect in cotranslational MBP export in SecB-cells.
In addition to SecB, other cytoplasmic protein factors from E. coli cells that could stimulate in vitro protein translocation activity have been identified. The 12S export factor of Muller and Blobel (2) is -220 kDa, and the "trigger factor" described by Crooke and Wickner (3) is -60 kDa. Weng et al. (4) described two factors of 60 and -120 kDa. None ofthese appear to be SecB. In addition, the isolation of temperaturesensitive mutants defective in protein export at the nonpermissive temperature led to the identification of SecA, a cytoplasmic 91-kDa protein (24) . The role that these various proteins have in promoting co-and/or posttranslational protein export has not yet been determined. Our studies indicate that the inability to attain 100% translocation efficiency of MBP in vitro is not associated with the vesicle fraction (J.B.W., unpublished data); rather, some proportion of the newly synthesized pre-MBP may fail to properly interact with one or more of these other soluble factors prior to delivery to the cytoplasmic membrane. Future use of purified SecB and the SecB-specific antiserum should help to define the interactions between MBP, SecB, and the various components of the export machinery.
